In an article called, “Trump coaxes big promises from big pharma,” Jane is quoted on the recent announcements from pharma companies who are reducing certain prescription drug prices through the end of 2018. ‘This is not a policy, this is self-regulation – these are ad hoc agreements that are verbal and can change,’ Jane explained. Check out the in-depth analysis by Rebecca Trager.